Terminally differentiated CD56<sup>neg</sup>CD16<sup>pos</sup> NK cells have been described after chronic viral and malaria infections, and in children diagnosed with Burkitt lymphoma (BL). The gene discussed is NCAM1; the disease is Burkitt lymphoma.